Status:
COMPLETED
Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT)
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiovascular disease and ischemic heart disease is the #1 killer in Canada. Currently, Cardiac invasive catheterization angiography (CICA) is the gold standard for the assessment of the arteries in ...
Eligibility Criteria
Inclusion
- Patients referred for Tc-99m SPECT or CTA; or
- Patients referred for CICA without preceding (\< 12 months) MPI or CTA
Exclusion
- Previous revascularization (PCI or CABG)
- Age \< 18 years or lack of consent
- Renal Insufficiency (GFR \< 60 ml/min)
- Allergy or contraindication to contrast agent or dipyridamole
- Refractory angina requiring urgent/emergent coronary angiography
- Contraindication to radiation exposure (e.g. pregnancy)
- Uncontrolled HR
- Atrial fibrillation, frequent atrial or ventricular ectopy (\> 1/minute)
- Unable to perform 10 second breath-hold
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00449943
Start Date
September 1 2006
End Date
December 1 2010
Last Update
January 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y 4W7